Expression of PD-1 and PD-L1 in poorly differentiated neuroendocrine carcinomas of the digestive system: A potential target for anti-PD-1/PD-L1 therapy
Human Pathology Oct 19, 2017
Roberts JA, et al. - This paper entailed the analysis of the expression of PD-1/PD-L1 pathway in poorly differentiated neuroendocrine carcinomas of the digestive system. PD-1/PD-L1 expression was determined to be a common occurrence in such tumors. Checkpoint blockade targeting the PD-1/PD-L1 pathway could display a potential role in the treatment of the study cohort.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
